Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1056_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •About the Editors
- •Contributors
- •3 Host Factors: Age, Gender, Lifestyle
- •4 IBD and Other Etiologically Relevant Comorbid Conditions
- •5 Anatomical Presentation and Rectovaginal Fistula
- •6 Anal Fistula Development: Microbiological Factors
- •7 Recurrence and Cancer Risk
- •8 Conclusion
- •References
- •1 Epidemiology of Anal Fistula and Abscess
- •1 Introduction
- •2 Incidence and Prevalence
- •2.1 Europe
- •2.2 USA and Canada
- •2 Anorectal Anatomy Related to Anal Fistula and Abscess
- •1 Introduction
- •2 Mucosal Layer and Submucosal Space
- •3 Internal Anal Sphincter
- •4 Intersphincteric Space and Conjoint Longitudinal Muscle
- •5 External Anal Sphincter
- •6 Pelvic Floor
- •7 Extra-anal Spaces/Ischioanal Fossae
- •8 Anal Glands
- •10 Conclusion
- •11 Cross-References
- •References
- •3 Anorectal Physiology Related to Anal Fistula and Abscess
- •1 Principal Aspects of Anorectal Physiology
- •1.1 Secretory Function of the Anorectum and the Cryptoglandular Hypothesis
- •1.2 Histology and Cellular Physiology of the Anorectum and Fistula
- •1.3 Microbiology and Fistula
- •1.4 Host Factors Relevant to Abscess and Fistula
- •1.5 Anal Continence
- •1.5.1 The Rectum
- •1.5.2 The Musculature of the Pelvic Floor and Sphincter Complex
- •1.6 Defecation
- •1.7 Anorectal Physiology Testing in the Context of Fistula
- •1.7.2 Perioperative Anorectal Physiology Testing
- •2 Conclusion
- •References
- •4 Unconventional Insights in the Pathogenesis and Etiology of Fistulas in the Perianal Region
- •1 Introduction
- •1.1 Etiology
- •1.2 Risk Factors for Development of Perianal Fistula
- •1.3 Risk Factors due to the Type of Perianal Fistula
- •1.4 Treatment-Related Risk Factors for Failure
- •1.5 Preliminary Conclusions
- •2.1 Anatomy of the Anal Canal
- •2.2 Histology of the Anal Canal
- •2.3 Histopathologic Concepts of Perianal Fistulas
- •3.1 Old Stories, New Histopathological Concepts?
- •3.2 Old Stories, New Clinical Concepts?
- •3.2.1 Basic Concepts
- •3.3 Based on Previous Medical History
- •3.4 Aspect and Localization of the Fistula Opening
- •3.5 Phenotype 1
- •3.6 Phenotype 2
- •3.7 Phenotype 3
- •3.8 Phenotype 4
- •3.9 Phenotype 5
- •4 Discussion and Conclusions
- •5 Cross-References
- •References
- •5 From Abscess to Fistula
- •1 Anorectal Abscess
- •References
- •6 Classification of Anal Fistula and Abscess
- •1 Introduction
- •2 Purpose and Attributes of a Classification
- •3 Overview of Anal Fistula Classifications
- •4 Anal Fistula Classifications
- •4.1 Parks Classification
- •4.1.1 Strong Points
- •4.1.2 Weak Points
- •5.1 Strong Points
- •5.2 Weak Points
- •6 Garg Classification
- •6.6 Strong Points
- •6.7 Weak Points
- •7 Status of Extrasphincteric Fistulas
- •8 Evaluation of Existing Classifications on Long-Term Data
- •9 Conclusions
- •References
- •7 Clinical Assessment of Anal Cryptoglandular Abscess and Fistula
- •1 Introduction
- •2 Types of Clinical Evaluation
- •3 Diagnosis
- •4 Topographic Evaluation
- •4.1 The Cryptic Endoanal Primary Opening
- •4.2 The Secondary Opening or Openings
- •4.3 The Main Tract of the Fistula
- •4.4 Possible Purulent Collections
- •1.1 Physical Examination of the Anus and Rectum: General Principles
- •4.5 Possible Secondary Extensions
- •5 Conclusion
- •References
- •8 Clinical Assessment of Crohn Perianal Abscesses and Fistulas
- •1 Introduction
- •1.2 Inspection
- •1.3 Palpation
- •1.4 Endoscopy
- •2 Clinical Presentation
- •2.1 Skin Lesions
- •2.2 Fistulas
- •2.3 Abscesses
- •2.4 Diagnostic Workup
- •2.4.1 General Principles
- •2.5 US
- •2.6 Effectiveness and Sensitivity
- •2.6.1 Endoscopy
- •2.7 MRI
- •2.7.1 CT Scan
- •2.7.2 Fistulography
- •2.8 Diagnostic Follow-up
- •References
- •9 Anorectal Physiology Assessment in Patients with Anal Fistula: When Necessary
- •1 Introduction
- •2 Anorectal Physiology Assessment
- •2.1 Anamnesis
- •2.2 Physical Examination
- •2.3 Anorectal Manometry
- •2.3.1 Equipment
- •2.3.2 Manometry Systems
- •2.4 Neurophysiologic Tests
- •2.4.1 Electromyography
- •2.4.2 Nerve Conduction Studies
- •2.5 Endoanal Ultrasound
- •2.6 Role of Anorectal Physiology Patterns in the Decision-Making
- •3 Discussion
- •References
- •1 Introduction
- •2 Anal Anatomy
- •3 Classification of Fistulas
- •4 EAUS Imaging
- •4.1 Probes EAUS
- •4.2 Performing EAUS
- •4.3 EUS in Perianal Fistulas
- •4.4 Adding Hydrogen Peroxide (H2O2)
- •4.5 Cryptoglandular Fistulas
- •5 Comparison with Other Diagnostic Modalities
- •5.1 Comparison with Surgery
- •5.2 Comparison with MRI
- •5.3 Perineal Ultrasound
- •6 Conclusion and Recommendation
- •References
- •1 Introduction
- •2 Imaging
- •2.1 Conventional Contrast Material-Enhanced Fistulography
- •2.2 CT
- •2.3 Magnetic Resonance Imaging
- •2.3.1 Anatomy MRI
- •2.3.2 MRI Technique (Coils, Volume, and Sequences) and Findings
- •2.3.3 MRI Reconstruction Techniques and Fistulography MRI
- •2.3.4 Internal and Cutaneous Opening
- •2.3.5 Classifications of Perianal Fistulas and Abscesses
- •2.3.6 Deep Posterior Anal Fistulas and Abscess
- •2.3.7 MRI Report
- •2.3.9 MR Role in the Evaluation of the Crypto-Glandular Fistulas
- •3 Conclusion
- •4 Cross-References
- •References
- •1 Introduction
- •2 Clinical Presentation
- •3 Utility and Limitations of Endoanal Ultrasound
- •4 Conclusion
- •5 Cross-References
- •References
- •1 Introduction
- •2 Imaging
- •3 Diagnosis
- •4 MRI Technique
- •5 Disease Monitoring
- •6 Future Directions
- •7 Conclusion
- •8 Cross-References
- •References
- •14 Future Perspectives in the Diagnosis of Anal Fistula and Abscess
- •1 Introduction
- •2 Assessment of Abscess and Anal Fistula
- •3 Abscess
- •3.1 Computed Tomography (CT)
- •3.2 Magnetic Resonance Imaging (MRI)
- •3.3 Endoanal Ultrasound
- •3.4 Transperineal Ultrasonography (TP-US)
- •4 Anal Fistula
- •4.1 Imaging
- •4.1.1 Endoanal Ultrasound
- •4.1.2 Magnetic Resonance Imaging
- •5 Conclusion
- •6 Cross-References
- •References
- •15 How to Drain an Abscess
- •1 Introduction
- •2 Epidemiology and Etiology
- •3 Classification
- •4 Clinical Manifestations and Diagnosis
- •5 Management
- •7 Wound Dressing
- •8 Microbiology and Antibiotics
- •9 General Postoperative Management
- •10 Conclusion
- •11 Cross-References
- •References
- •16 The Seton in Anal Fistula Management
- •1 Introduction
- •2 2500 Years of Setons
- •3 To Put or Not to Put
- •4 To Cut or Not to Cut
- •5 What Kind of Seton to Use?
- •7 Seton 2.0: New Perspectives
- •8 Uncomfortable Questions (How to Do It)
- •9 What Patients Should Know
- •10 Conclusions: Seton in Guidelines
- •References
- •17 Fistulotomy
- •1 Introduction
- •2 Indications
- •3 Fistulotomy: Standard Technique
- •4 Other Fistulotomy Techniques
- •4.1 Addition of Loose Seton
- •4.2 Slow Dissection of the Sphincter: Cutting Seton
- •4.3 Addition of Marsupialization
- •5 Fistulotomy with Immediate Primary Sphincteroplasty (FIPS)
- •7 Postoperative Care
- •8 Complications and Recurrence Rate
- •9 Discussion
- •10 Conclusion
- •References
- •18 Fistulectomy
- •1 Introduction
- •2 Preoperative Evaluation
- •2.1 Patient Selection
- •2.2 Imaging
- •2.3 Physiologic Testing
- •2.4 Endoscopic Examination
- •3 Technique
- •3.1 Patient Preparation
- •3.2 Patient Positioning
- •3.2.1 Technical Steps
- •4 Postoperative Care
- •5 Results
- •5.1 Fistulectomy
- •6 Fistulectomy with Sphincter Reconstruction
- •7 Conclusions
- •References
- •19 Utility of Adding Sphincter Reconstruction to Fistulotomy/Fistulectomy
- •1 Introduction
- •2 General Classification
- •3 Preoperative Preparation
- •4 Surgical Technique Step by Step
- •5 Results
- •6 Conclusion
- •7 Cross-References
- •References
- •20 Utility of Marsupialization Following Anal Fistula Surgery
- •1 Introduction
- •2 Marsupialization
- •3 Clinical Evidence
- •4 Conclusion
- •References
- •21 Transanal Advancement Flap Repair
- •1 Introduction
- •2 Nomenclature
- •3 Effectiveness of the Technique
- •4 Effectiveness of Repeat Procedures
- •5 Impact on Fecal Continence
- •6 Severity of Incontinence
- •7 Perioperative Care
- •7.1 Bowel Preparation
- •7.2 Antibiotic Prophylaxis
- •7.3 Prolonged Antibiotic Therapy
- •7.4 Type of Anesthesia
- •7.5 Immobilization
- •7.6 Bowel Confinement
- •7.7 Stool Softeners
- •7.8 Position
- •8 Aspects of Surgical Technique
- •8.1 Preoperative Care
- •8.2 Step 1
- •8.3 Step 2
- •8.4 Step 3
- •8.5 Step 4
- •8.6 Step 5
- •8.7 Postoperative Care
- •8.8 Types of Flap
- •8.9 Shape of Flap
- •8.10 Thickness of Flap
- •8.11 Addition of Accessory Techniques
- •9 Necessity of Preoperative Imaging
- •10 Factors Contributing to Successful Healing
- •10.1 Fistula-Related Factors
- •10.2 Patient-Related Factors
- •10.3 Influence of Covering Ostomy
- •10.4 Impact of the Use of Draining Setons
- •11 Conclusion
- •References
- •22 Dermal Flap Anoplasty for Trans-sphincteric Anal Fistula
- •1 Rationale
- •2 Technique
- •3 Other Dermal Flaps
- •4 Discussion
- •5 Cross-References
- •References
- •23 (LIFT) Ligation of Intersphincteric Fistula Tract
- •References
- •24 Anal Fistula: Glue and Paste Injection
- •1 Introduction
- •2 Fibrin Glue
- •3 Collagen Paste
- •4 Conclusion
- •5 Cross-References
- •References
- •25 VAAFT
- •1 Introduction
- •1.1 VAAFT Story
- •2 Surgical Equipment and Accessories
- •3 VAAFT Indications
- •3.1 Preoperative Assessment
- •4 VAAFT Procedure
- •4.1 Diagnostic Phase (Fistuloscopy)
- •4.2 Operative Phase
- •5 Closure of the Internal Opening
- •5.1 Use of a Linear or Semicircular Stapler
- •5.2 Advancement Flap
- •5.3 Use of a Bioabsorbable Mesh (Xenograft)
- •5.4 Autologous Dermis Graft
- •5.4.1 VAAFT Associated to the LIFT Procedure
- •5.5 Postoperative Management
- •6 Discussion
- •7 Conclusions
- •References
- •26 The Laser Treatment of Anal Fistulas
- •1 Introduction
- •1.1 Literature Review
- •1.3 Diagnosis and Treatment of Complex Anal Fistulas
- •2 Materials and Methods
- •3 Conclusion
- •References
- •27 Treatment by Over-the-Scope-Clip
- •1 Introduction
- •2 Technical Background
- •3 Surgical Application
- •4 Principle of Action
- •5 Clinical Data
- •References
- •28 Stem Cells in Cryptoglandular Anal Fistulas
- •1 Introduction
- •2 History of a Novel Approach
- •2.1 Mesenchymal Stem Cells
- •2.2 Adipose Tissue: The Ideal MSCs Source
- •2.3 Adipose Tissue Graft
- •2.3.1 Lipogems
- •3 Results
- •3.1 Literature Review
- •3.2 Personal Experience
- •4 Discussion and Conclusion
- •References
- •1 Introduction
- •2 Perianal and Rectovaginal Fistulas
- •2.1 Epidemiology and Diagnosis
- •2.2 Classification
- •2.3 Treatment Modalities
- •3 Flap Reconstruction
- •3.1 Overview and Considerations for Flap Reconstruction
- •4 Gracilis Interposition Flap
- •4.1 Background and Indications
- •4.2 Operative Technique
- •4.3 Results/Complications
- •5 Martius Interposition Flap
- •5.1 History and Indications
- •5.2 Surgical Technique
- •5.3 Results/Complications
- •6 Gluteal Muscle Interposition Flap
- •6.1 History and Indications
- •6.2 Surgical Technique
- •6.3 Results/Complications
- •7 Conclusion
- •References
- •30 Quality of Life Following Anal Fistula Treatment
- •1 Introduction
- •2 Quality of Life with an Anal Fistula
- •2.1 Cryptoglandular Fistulas
- •2.3 Conclusion
- •3 Quality of Life with a Seton and a Fistula

488 D. Morte et al.
a 65% success rate in 23 patients, in which of note, 70% of these patients were
diverted. The most frequent complication is dyspareunia, which is reported in up to
30% of patients by 6 weeks postoperatively, with the next most frequent complication being labial wound issues in <10% (McNevin et al. 2007).
6 Gluteal Muscle Interposition Flap
6.1 History and Indications
Gluteal flaps have been used as local-regional fasciocutaneous flaps for vulvar and
vaginal reconstruction due to their ability to cover large defects. They have the
benefit of having consistent vascular an atomy, reliable vascularity, ability to be
raised in many positions, adequate bulk, minimal sequelae, and well-hidden donor
scars (Pantelides et al. 2013). They have more recently been described for the repair
of rectovaginal fistulas following rectal cancer surgery as a means for providing a
robust flap and tissue pedicle (Kosugi et al. 2005). This is beneficial in pati ents that
have undergone multiple prior repairs for a recurrent rectovaginal fistula and are at a
high risk for recurrence. However, there have been few studies that have reviewed
the clinical features or operative techniques of the use of gluteal fold flaps for the
repair of rectovaginal fistulas.
6.2 Surgical Technique
Kosugi and associates (2005) describe the following technique for perfor ming a
gluteal fold flap repair for a rectovaginal fistula following rectal cancer resection.
Patients typically receive a mechanical bowel preparation and intravenous antibiotics preoperatively. They are placed into the lithotomy position. The vaginal and
rectovaginal fistula openings are identified, and a transvaginal incision is made
around the fistula tract. The edges of the incision are undermined circumferentially
until the external rectal muscular layer is encountered. The fistula is divided and
debrided, and the rectal opening of the fistula is closed using two layers of absorbable sutures in an interrupted horizontal mattress fashion.
The proposed gluteal fold flap is drawn with a skin marker and the flap created
with an incision along the poste rolateral margin of the vaginal introitus. The shape
can be triangular or diamond-shaped and consists of skin, subcutaneous fat, and
superficial fascia. It is important to remember that the blood supply from the internal
pudendal artery reliably runs just medial to the ischial tuberosity, and there may be
several additional perforating vessels (Fig. 12). If the flap appears to have excessive
bulk, it can be thinned without too much concern for compromising the blood supply
(Hashimoto et al. 2001). The flap is turned 180 degrees and advanced into the

29 Additional Surgical Options to Treat Anal Fistulas: Gracilis... 489
Fig. 12 Gluteal flap blood
supply is from the internal
pudendal artery which reliably
runs medial to the ischial
tuberosity. (Reprinted with
permission, Cleveland Clinic
Center for Medical Art &
Photography © 2020. All
Rights Reserved)
vagina. Absorbable interrupted sutures are used to suture the flap to the vagina
mucosa, covering the fistula tract and opening. The gluteal skin defect is closed
primarily (Fig. 13). Drains are routinely placed under the tissue of the flap.
A diverting loop ileostomy or transverse colostomy can be created if it was not
performed preoperatively.
6.3 Results/Complications
While there is a scarcity of data regarding the specific use of gluteal flaps in the repair
of rectovaginal fistulas, it has shown great promise in a small study completed by
Kosugi et al. (2005). They report that in five patients receiving a gluteal flap repair,
there was no relapse of a rectovaginal fistula after greater than 1 year of postoperative monitoring. There were also no complications noted at follow-up. This has
been supported in literature regarding the use of gluteal fold flaps in perianal
reconstruction. Windhofer et al. (2011) reported complete healing in 13/14 patients,
with the only complications encountered being wound dehiscence and partial flap
necrosis. Ragoowansi et al. (2004) reported 86% of patients had complete healing,
11% had partial flap necrosis secondary to excessive skeletonization of the vascular
pedicle, and 3% had complete necrosis requiring split-thickness skin graft

490 D. Morte et al.
Fig. 13 Completed gluteal
flap after 180 degree rotation
to cover perineal/vaginal
defect. (Reprinted with
permission, Cleveland Clinic
Center for Medical Art &
Photography © 2020. All
Rights Reserved)
reconstruction. Only 19% of the flaps retained protective sensation, and 17% of
patients were able to return to sexual activity following reconstruction.
There are several potential limitations regarding the use of gluteal fold flaps. The
first is the underlying disease process can cause compromise to the integrity of the
required skin for the flap, such as in the setting of Crohn’s disease and multiple
perianal fistulas or excessive scarring from multiple prior repairs (Shahzad et al.
2014). The flap also has a limited width of approximately eight centimeters which
may preclude repair of high fistulas. It is also recommended that patients not sit on
the donor site for at least 3 weeks postoperatively which can be difficult for patients
to be compliant with. Nonetheless, the gluteal fold flaps remain a viable option in the
repair of rectovaginal fistulas.
7 Conclusion
Perianal and rectovaginal fistulas are a difficult disease process for both patients and
surgeons alike. They have a wide range of presentation, causes, and treatments with
no well-defined guidelines or algorithms regarding progression of treatment. It is
important to have a comprehensive understanding of the underlying disease process
and available options for effective treatment as they can have major psychological
and significant effects on quality of life from failure or postoperative complications.

29 Additional Surgical Options to Treat Anal Fistulas: Gracilis... 491
Table 1 Summary of success, complications, and recurrences in the three primary flap procedures
for rectovaginal fistula treatment
Success Complications Recurrence Additional
Gracilis
flap
Martius
flap
Gluteal
flap
All procedures at risk of flap failure and infection
83% Thigh
65% Dyspareunia
Limited
data
paresthesia (2%)
(30%)
Buttock
paresthesia
58%
6%
0/5 in small study
(Kosugi)
Sitting precautions
Skin issues related to
disease process
Muscle interposition flaps are an effective and successful intervention when used in
the correct setting and should be considered for patients with recurrent fistulas
(Table 1).
References
Bailez MM, Cuenca ES, Di Benedetto V et al (2010) Laparoscopic treatment of rectovaginal
fistulas. Feasibility, technical details, and functional results of a rare anorectal malformations.
J Pediatr Surg 45(9):1837–1842
Bernstein AM, Schehebar JA (2020) Rectovaginal fistula. In: Current surgical therapy, 13th edn,
Elsevier, pp 320–330
Chen XB, Liao DX, Luo CH et al (2013) Prospective study of gracilis muscle repair of complex
rectovaginal fistula and rectourethral fistula. Zhonghua Wei Chang Wai Ke Za Zhi 16(1):52–55
Cologne KG, Langenfeld SJ (2020) Management of anorectal abscess and fistula. In: Current
surgical therapy, 13th edn, Elsevier, pp 298–307
Corman ML (1979) Management of fecal incontinence by gracilis muscle transposition. Dis Colon
Rectum 22:290–2
Corte H, Maggoiori L, Treton X, Lefevre JH et al (2015) Rectovaginal fistula: what is the optimal
strategy?: an analysis of 79 patients undergoing 286 procedures. Ann Surg 262(5):855–860.
discussion 851–860
Daniels BT (1949) Rectovaginal fistula: a clinical and pathological study [Master’s thesis]. Uni-
versity of Minnesota Graduate School, Minneapolis
Furst A, Schmidbauer C, Swol-Ben J et al (2008) Gracilis transposition for repair of recurrent
anovaginal and rectovaginal fistulas in Crohn’s disease. Int J Color Dis 23:349–353
Gajsek U, McArthur DR, Sagar PM (2011) Long-term efficacy of the button fistula plug in the
treatment of Ileal pouch-vaginal and Crohn’s related rectovaginal fistulas. Dis Colon Rectum 54:
999–1002
Galandiuk S, Kimberling J, Al-Mishlab TG et al (2005) Perianal Crohn disease: predictors of need
for permanent diversion. Ann Surg 241(5):796–801. discussion 801–802
Gazala MA, Steven DW (2017) Management of rectovaginal fistulas and patient outcome. Expert
Rev Gastroenterol Hepatol 11(5):461–471. https://doi.org/10.1080/17474124.2017.1296355.
Epub 2017 Mar 1
Gonsalves S, Sagar P, Lengyel J, Morrison C, Dunham R et al (2009) Assessment of the efficacy of
the rectovaginal button fistula plug for the treatment of ileal pouch-vaginal and rectovaginal
fistulas. Dis Colon Rectum 52(11):1877–1881

492 D. Morte et al.
Gottgens KW, Smeets RR, Stassen LP et al (2014) The disappointing quality of published studies
on operative techniques for rectovaginal fistulas: a blueprint for a prospective Multi-institutional
Study. Dis Colon Rectum 57:888–898
Halverson AL, Hull TL, Fazio VW et al (2011) Repair of recurrent rectovaginal fistulas. Surgery
130:753–757
Hashimoto I, Nakanishi N, Nagae H et al (2001) The gluteal-fold flap for vulvar and buttock
reconstruction: anatomic study and adjustment of flap volume. Plast Reconstr Surg 108:
1998–2005
Hrabe JE, Hull TL (2020) Anal conditions: rectovaginal fistula. Springer Surgical Therapy, Springer
Hull TL, el-Gazzaz G, Gurland B et al (2011) Surgeons should not hesitate to perform
episioproctotomy for rectovaginal fistula secondary to cryptoglandular or obstetrical origin.
Dis Colon Rectum 54(1):54–59
Kin C, Gurland B, Zutshi M et al (2012) Martius flap repair for complex rectovaginal fistula. Pol
Przegl Chir 84:601–604
Kniery K, Johnson E, Steele S (2015) How I do it: Martius flap for rectovaginal fistulas.
J Gastrointest Surg 19:570–574
Korsun S, Liebig-Hoerl G, Fuerst A (2019) Gracilis muscle transposition for treatment of recurrent
anovaginal, rectovaginal, rectourethral, and pouch-vaginal fistulas in patients with inflammatory
bowel disease. Techniq Coloprocotol 23:43–52
Kosugi C, Saito N, Kimata Y et al (2005) Rectovaginal fistulas after rectal cancer surgery: incidence
and operative repair by gluteal-fold flap repair. Surgery 137:329–336
Lefevre JH, Bretagnol F, Maggiori L et al (2009) Operative results and quality of life after gracilis
muscle transposition for recurrent rectovaginal fistula. Dis Colon Rectum 52:1290–1295
Levitt MA, Pena A (2005) Outcomes from the correction of anorectal malformations. Curr Opin
Pediatr 17(3):394–401
McNevin MS, Lee PY, Bax TW (2007) Martius flap: an adjunct for repair of complex, low
rectovaginal fistula. Am J Surg 193:597–599. discussion 599
Mennigen R, Heptner B, Senninger N, et al (2015) Temporary fecal diversion in the management of
colorectal and perianal Crohn’s disease. Gastroenterol Res Pract
Moore RD, Miklos JR, Kohli N (2004) Rectovaginal fistula repair using a porcine derma graft.
Obstet Gynecol 104(5 pt 2):1165–1167
Mueller MH, Geis M, Glatzle J, Kasparek M, Meile T, Jehle EC, Kreis ME, Zittel TT (2007) Risk of
fecal diversion in complicated perianal crohn’s disease. J Gastrointest Surg 11(4):529–37.
https://doi.org/10.1007/s11605-006-0029-3
Pantelides NM, Davies RJ, Fearnhead NS et al (2013) The gluteal fold
perineal reconstruction following anorectal cancer resection. J Plast Reconstr Aesthet Surg 66:
812–820
Pinto RA, Peterson TV, Shawki S et al (2010) Are there predictors of outcome following
rectovaginal fistula repair? Dis Colon Rectum 9:1240–1247
Pitel S, Lefevre JH, Parc Y et al (2011) Martius advancement flap for low rectovaginal fistula: short-
and long-term results. Color Dis 13(6):112–115
Radcliffe AG, Ritchie JK, Hawley PR et al (1988) Anovaginal and rectovaginal fistulas in Crohn’s
disease. Dis Colon Rectum. https://doi.org/10.1007/BF02562636
Ragoowansi R, Yii N, Niranjan N (2004) Immediate vulvar and vaginal reconstruction using the
gluteal-fold flap: long-term results. Br J Plast Surg 57(5):406–410
Ruffolo C, Scarpa M, Bassi N et al (2010) A systematic review on advancement flaps for
rectrovaginal fistula in Crohn’s disease: transrectal vs transvaginal approach. Color Dis
12(12):1183–1191
Schouten WR, Oom DM (2009) Rectal sleeve advancement for the treatment of persistent
rectovaginal fistulas. Tech Coloproctol 13:289–294
Schwandner O, Fuerst A (2009) Preliminary results on efficacy in closure of Transphincteric and
rectovaginal fistulas associated with Crohn’s disease using new biomaterials. Surg Innov 16(2):
162–168
flap: a versatile option for

29 Additional Surgical Options to Treat Anal Fistulas: Gracilis... 493
Schwartz DA, Loftus EV Jr, Tremaine WJ et al (2002) The natural history of fistulizing Crohn’s
disease in Olmsted County, Minnesota. Gastroenterology 122(4):875–880
Senatore PJ Jr (1994) Anovaginal fistulae. Surg Clin North Am 74(6):1361–1375
Shahzad F, Wong KY, Di Candia M et al (2014) Gluteal fold flap in perineal reconstruction for
Crohn’s disease-associated fistulae. J Plast Reconstr Aesthet Surg 67:1587–1590
Singh B, McC Mortensen NJ, Jewell DP et al (2004) Perianal Crohn’s disease. Br J Surg 91(7):
801–814
Tiwari C, Shah H, Bothra J et al (2017) Congenital rectovaginal fistula with anorectal agenesis: a
rare anorectal malformation. Int J Pediatr Adolesc Med 4(4):138–140
Tsang CB, Rothenberger DA (1997) Rectovaginal fistulas. Therapeutic options. Surg Clin North
Am 77(1):95–114
Van Der Hagen SJ, Soeters PB, Baeten CG et al (2011) Laparoscopic fistula excision and
omentoplasty for high rectovaginal fistulas: a prospective study of 40 patients. Int J Color Dis
26(11):1463–1467
Vander Mijnsbrugge GHJ, Felt-Bersma RJF, Ho DKF et al (2019) Perianal fistulas and the lift
procedure: results, predictive factors for success, and long-term results with subsequent treat-
ment. Tech Coloproctol 23:639–647
Wexner SD, Ruiz DE, Genua J et al (2008) Gracilis muscle interposition for the treatment of
rectrourethra, rectovaginal, and pouch-vaginal fistuals: results in 53 patients. Ann Surg 248(1):
39–43
White AJ, Buchsbaum HJ, Blyth JG et al (1982) Use of the bulbocavernosus muscle (Martius
procedure) for repair of radiation-induced rectovaginal fistulas. Obstet Gynecol 60:114–118
Windhofer C, Michlits W, Heuberger A et al (2011) Perineal reconstruction after rectal and anal
disease using the local fascio-cutaneous-infragluteal flap: a new and reliable technique. Surgery
149(2):284–290
Wiskind AK, Thompson JD (1992) Transverse transperineal repair of rectovaginal fistulas in the
lower vagin. Am J Obstet Gynecol 167:694–699
Zmora O, Tulchinski H, Gur E et al (2006) Gracilis muscle transposition for fistulas between the
recum and urethra or vagina. Dis Colon Rectum 49:1316–1321

Quality of Life Following Anal Fistula Treatment
Dieter Hahnloser
Contents
1 Introduction . ............... .................................................................. 496
2 Quality of Life with an Anal Fistula .................................. ...................... 496
2.1 Cryptoglandular Fistulas ................................... ........................... 496
2.2 Crohn’s Anal Fistula ............................. ............................. ........ 497
2.3 Conclusion ............................................................................. 498
3 Quality of Life with a Seton and a Fistula .................................................. 498
3.1 Conclusion ............................................................................. 499
4 Quality of Life After Fistula Treatment ..................................................... 499
4.1 Simple Anal Fistula (Fistulotomy) .................................................... 499
4.2 Anal Fistula Plug . ..... . .................... ........................................... 500
4.3 Advancement Flap .................................................................... 500
4.4 Lift ............................................ ......................................... 501
4.5 Video-Assisted Anal Fistula Treatment (VAAFT) . ................................... 501
4.6 Sexual Function ..... ................................. ................................. 501
4.7 Conclusion ............................................................................. 501
5 Cross-References .......................... ............................................. ..... 502
References ............................ ............................................... ............ 502
30
Abstract
The symptoms most frequently associated with an anal fistula include suppuration, bleeding, and/or pain, which are often preceded by the drainage of a perianal
abscess and seton placement. All can severely affect patient’s quality of life
(QoL). Patients with anal fistula have a reduced QoL, which is worse with
recurrent disease, secondary extensions, and urgency. Setons should be placed
loosely and should be comfortable. Their main goal is to relieve symptoms,
prevent perianal sepsis, and to condition the fistula for reparative surgery. QoL
is improved and continence is not impaired with a seton. Patients undergoing
D. Hahnloser (*)
Department of Visceral Surgery, University Hospital Lausanne, Lausanne, Switzerland
e-mail: dieter.hahnloser@chuv.ch
© Springer Nature Switzerland AG 2022
C. Ratto et al. (eds.), Anal Fistula and Abscess, Coloproctology,
https://doi.org/10.1007/978-3-030-76670-2_33
495

496 D. Hahnloser
fistula surgery have only a 50–70% chance of cure. They should be counseled
appropriately and warned that multiple interventions may be necessary. Fortunately, major symptoms such as pain and discharge improve and the risk of
incontinence following fistula surgery is low. Patients can expect an improvement
in symptom-specific QoL. Core outcome sets and specific validated QoL questionnaires should be used in the future to compare outcomes.
Keywords
Quality of Life · QoL · Anal fistula · Functional outcome · Urgency ·
Incontionence
1 Introduction
The symptoms most frequently associated with an anal fistula include suppuration,
bleeding, and/or pain, which are often preceded by the drainage of a perianal abscess
and seton placement. All can severely affect patient’s quality of life (QoL). Treatment of anal fistulas can affect fecal continence, which also impairs QoL. In the light
of this, patient’s QoL emerges as an important indicator that should be taken into
consideration when making individualized decisions on the treatment strategy.
“Civilization rests on two things, the discovery that fermentation produces
alcohol, and the voluntary ability to inhibit defecation” (Robertson Davies, The
Rebel Angels, 1981). The biggest fear of fistula treatment is impairment of fecal
continence. Therefore, the goal of any anal fistula treatment must be: first to preserve
fecal continence (and maintain a qood QoL) and secondly to cure the fistula.
“Recurrence is better than total incontinence” (unknown).
In this chapter, three aspects of QoL in anal fistula will be discussed: QoL with an
anal fistula, QoL with a seton, and finally QoL after anal fistula treatment.
2 Quality of Life with an Anal Fistula
2.1 Cryptoglandular Fistulas
A study from the St. Mark’s Clinic in 146 patients (median age of 44 years) with
cryptoglandular fistulas assessed QoL using the St Mark’s Incontinence Score and
the short form-36 Health survey (SF-36) questionnaire at the point of referral (Owen
et al. 2016). In general, QoL worsened with increasing incontinence scores. However, none of the SF-36 domains showed a strong correlation with continence score,
with a fair correlation found between continence score and the Physical Functioning
domain. QoL in recurrent fistula (22% in this study) was significantly worse than in
patients with a primary fistula on two domains of physical and social functioning.
Setons (in 35% of patients) and secondary extensions (22%) had no impact on
continence nor on QoL. Urgency (present in 24% and defined as the inability to

30 Quality of Life Following Anal Fistula Treatment 497
defer defecation for 15 min) correlated with a median continence score of 11, however, was similar in patients with or without a seton or a secondary extension. In
summary, patients with anal fistula had a reduced QoL, which was worse in those
with recurrent disease, secondary extensions, and urgency. However, loose seton had
no impact on QoL.
A Spanish study developed and validated a Quality of Life in Patients with Anal
Fistula Questionnaire (QoLAFQ) (Ferrer-Marquez et al. 2017). This questionnaire
specifically measures quality of life in people with anal fistula from zero impact
(14 points) to very high impact (57–70 points). The questionnaire focuses on
physical aspects on QoL such as discharge, bleeding, noncontrolled flatulence, and
pain, as well as on biopsychosocial aspects such as subjective health perception
(physical and psychological), independence, social relation, sexual life, and attitude.
The same authors prospectively evaluated 80 patients using their QoLAFQ (FerrerMarquez et al. 2018). QoL was significantly worse in recurrent fistulas and in
patients with <6 months of symptoms. Patients with clinical symptoms >6 months
up to 5 years seem to adapt or cope with the situation and impact on QoL is less.
There were no statistically significant differences between QoL among patients
diagnosed with complex or simple fistulae. The QoLAFQ could contribute to the
evaluation of QoL among patients with cryptoglandular anal fistula, however, is not
widely used.
The development of an European cryptoglandular Anal Fistula Core Outcome Set
(AFCOS) is currently being conducted through an international Delphi consensus
(Machielsen et al. 2020).
2.2 Crohn’s Anal Fistula
The impact of perianal fistula(s) on patients with Crohn’s disease is intense and wide
reaching, negatively affecting intimate, close, and social relationships. Fistulas cause
losses in life and work-related opportunities, and treatments can be difficult to
tolerate. Crohn’s perianal fistulas exert a heavy negative physical and emotional
impact on patients. These findings of 12 standardized interviews helped to develop
patient reported outcome measures (PROM) to assess treatment effectiveness and
QoL for patients living with peria nal Crohn’s disease fistula (Adegbola et al. 2020b).
The current literature on perianal Crohn’s fistula is limited by a lack of standardized outcome measures. Several authors proposed a core outcome set (COS)
reflecting the minimum outcomes that should be reported in all trials (Sahnan et al.
2019; Ma et al. 2019). The COS contains patient- and clinician-reported outcomes.
The patient-reported outcomes are:
• Global assessment of quality of life
• Combined score of patient priorities on
– Lifestyle restriction (general)
– Lifestyle restriction based on toileting needs
– Depression

498 D. Hahnloser
– Inability to attend school/work and restriction of sexual activity and avoidance
of intimacy.
• Global assessment of incontinence.
This COS still requires international validation. It is also necessary to develop a
core measurement set, a collection of measurement tools, and standards by which
these outcomes can be assessed in a given study.
In 2020, data from 211 patients contributed to the development of a final 28-item
questionnaire, the Crohn’s Anal Fistula Quality of Life (CAF-QoL) (Adegbola et al.
2020a). The CAF-QoL covers the three domains of symptoms, effect of current
fistula treatment, and impact on QoL over the last 6 – 8 weeks. The questionnaire
demonstrated good internal consistency, excellent stability, and good responsiveness
and construct validity. The CAF-QoL scale is ready for use as a PROM in research
and clinical practice. It complements objective clinical evaluation of fistula by
capturing impact on the patient.
2.3 Conclusion
Anal fistulae (cryptoglandular of Crohn’s) have a negative impact on QoL.
Patients with recurrent fistula and with secondary extensions had even more
reduced QoL. Validated questionnaires are available and COS are being developed. They should be used to report any outcome of anal fistula treatment.
3 Quality of Life with a Seton and a Fistula
A loose seton is placed to stimulate fibrosis and to condition the fistula tract for
reparative surgery. Cutting setons are placed to strangulate the tract and slowly
transsect the sphincter. Cutting setons should not be used for high anal fistula as
they can cause moderate incontinence (St. Mark’s score of 6–12) in 13.5% of
patients and severe incontinence (score >12) in 8.5% and therefore negatively
impact QoL (Patton et al. 2015).
A seton should be placed loosely and should be comfortable. In a study comparing the comfort drain to a regular silicon drain for complex anal fistula, patients
experienced improved QoL with significant higher median physical and mental
health scores compared with a conventional loose seton (Kristo et al. 2016).
According to the visual analog scale (VAS), patients with a Comfort Drain in situ
reported greater perianal comfort with significantly less burning sensation and
pruritus. Fecal continence was similar in each group. A knot-free seton offers
significant improved quality of life and perianal comfort and could therefore facilitate long-term treatment of complex anal fistula. Many such comfortable drains are
available on the market. However, surgeons still use most frequently vessel loops or
nonabsorbable sutures 4–0or3–0.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
